CD28 and rheumatoid arthritis: We tested whether stimulating RA or PsA PBMC and SFMC in vitro with anti‐CD3 and CD28 mAbs in the presence of IL‐1β and IL‐23 would induce IL‐17F+ CD4+ T cells.